Pharmaceutical firm Eli Lilly has become the latest huge company to take aim at the UK, following Merck, AstraZeneca and others criticising the investing landscape and pricing approach compared to other nations. The drugmakers appear to be trying to collectively fashion a more favourable environment to produce and sell in the country, following the government putting life sciences as one of their key pillars in this year’s business growth strategy.
Elsewhere retailer JD Sports have said they expect “limited” impact on profits from US tariffs, but also say there is “elevated unemployment risk” going forward. Amazon have announced plans to shut all of their Fresh grocery stores in the UK.
